01 / Contract Profile
75A50120C00092 Federal Contract Award
Agency code 7505
THE PURPOSE OF THIS MODIFICATION IS TO THE EXTEND THE PLANNED DEFINITIZATION DATE OF THE CHANGE ORDER ISSUED ON P00022 FROM JULY 3, 2026 TO SEPTEMBER 3, 2026.
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75A50120C00092 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$80.27M
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2020 | $354.26M | 1 | — |
| FY 2021 | $87.00M | 2 | −75.4% |
| FY 2022 | $0 | 2 | −100.0% |
| FY 2023 | $50.65M | 4 | — |
| FY 2024 | $91.12M | 8 | +79.9% |
| FY 2025 | $33.37M | 8 | −63.4% |
| FY 2026 | $80.27M | 12 | +140.6% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | ASPR/DAAPPO/ORM HQ |
05 / Contractor
Who holds this federal contract?
PHLOW CORP.
UEI ZZN7NVV7JKG9 · CAGE 8HXQ3
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $696.67M | 37 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN17 | R&D- MEDICAL: BIOMEDICAL (COMMERCIALIZED) | $696.67M | 37 | 100.0% |
08 / Place of Performance
Where is the work recorded?
RICHMOND, RICHMOND CITY, VIRGINIA, UNITED STATES
ZIP 232191441
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Jul 2, 2026 | P00036 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Jun 30, 2026 | P00035 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Jun 24, 2026 | P00034 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| May 15, 2026 | P00033 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Apr 30, 2026 | P00032 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Apr 24, 2026 | P00031 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Mar 3, 2026 | P00030 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Feb 19, 2026 | P00029 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Jan 30, 2026 | P00028 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Jan 26, 2026 | P00027 | $53.90M | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Jan 26, 2026 | P00026 | $26.37M | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Jan 5, 2026 | P00025 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Dec 12, 2025 | P00024 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Dec 1, 2025 | P00023 | $0 | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
| Nov 4, 2025 | P00022 | $25.00M | ASPR/DAAPPO/ORM HQOffice code 75A502 | 325412 | AN17 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.